
zzso zzso zzso zzso is zzso in a panel of pancreatic cancer cells and tissue samples from pancreatic cancer zzso Ron can be activated by its zzso zzso stimulating protein zzso thereby zzso zzso signaling zzso zzso between Ron and zzso zzso or zzso may provide a mechanism underlying drug zzso Thus, targeting Ron may represent a novel therapeutic zzso zzso is the first Ron zzso zzso zzso entering clinical trial for targeting Ron zzso Our studies show zzso zzso Ron expression in pancreatic cancer cells and significantly blocked zzso Ron zzso downstream zzso and zzso zzso and zzso zzso zzso zzso hindered zzso cell migration and reduced cell zzso zzso zzso zzso zzso are reported to target expression of various genes through modification of zzso zzso and zzso zzso Our work shows zzso zzso and zzso zzso decreased Ron zzso and protein expression in pancreatic cancer zzso zzso also reduced downstream signaling of zzso zzso and zzso as well as enhanced cell zzso Interestingly, zzso reduced colony formation in Ron zzso cells to a greater extent than Ron scramble control cells in colony formation and soft zzso zzso zzso could also sensitize pancreatic cancer cells to zzso as reflected by reduced colony numbers and size in combination treatment with zzso and zzso compared to single treatment zzso The zzso further reduced Ron expression and zzso and increased zzso zzso compared to either treatment zzso This study suggests the potential for a novel combination approach which may ultimately be of value in treatment of pancreatic zzso 

